Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Co.'s Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions.
When researching a stock like Charles River Laboratories International, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from CRL Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for CRL stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the CRL 200 day moving average ("CRL 200 DMA"), while one of the most popular "shorter look-backs" is the CRL 50 day moving average ("CRL 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Charles River Laboratories International. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the CRL 200 DMA and the CRL 50 DMA, we get a moving average convergence divergence indicator ("CRL MACD"). The CRL MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart). |